4-氨基-4-氟联苯 | 324-93-6

• 物质功能分类: 化学试剂 - 有机试剂 - 多环化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氨基-4-氟联苯
• 中文别名: 4'-氟-联苯-4-胺
• 英文名称: 4-amino-4'-fluorobiphenyl
• 英文别名: 4'-fluoro-[1,1'-biphenyl]-4-amine；4-(4'-fluorophenyl)-aniline；4'-fluorobiphenyl-4-amine；4-(4-fluorophenyl)aniline
• CAS: 324-93-6
• 化学式: C₁₂H₁₀FN
• 分子量: 187.217
• InChiKey: HTRVALPKPVGOSZ-UHFFFAOYSA-N

物化性质

• 熔点：
  119-121°C
• 沸点：
  306.6±17.0 °C(Predicted)
• 密度：
  1.1388 (estimate)
• 溶解度：
  乙腈（微溶）、氯仿（微溶）、二氯甲烷（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  T
• 危险类别码：
  R23/24/25,R33
• 海关编码：
  2921499090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(4-Fluorophenyl)aniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(4-Fluorophenyl)aniline
CAS number: 324-93-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H10FN
Molecular weight: 187.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

类别：有毒物品

毒性分级：高毒

急性毒性：

• 口服 - 大鼠 LD50: 300 毫克/公斤

可燃性危险特性：

• 可燃；燃烧会产生有毒的氮氧化物和氟化物烟雾

储运特性：

• 库房应通风、低温且干燥

灭火剂：

• 干粉、泡沫、砂土、二氧化碳或雾状水

反应信息

• 作为反应物：
  描述：

  4-氨基-4-氟联苯 在 盐酸 、 sodium nitrite 、 potassium iodide 作用下， 以 水 为溶剂， 生成 4-fluoro-4'-iodo-1,1'-biphenyl
  参考文献：
  名称：

  Design and synthesis of boronic acid inhibitors of endothelial lipase

  摘要：

  Endothelial lipase (EL) and lipoprotein lipase (LPL) are homologous lipases that act on plasma lipoproteins. EL is predominantly a phospholipase and appears to be a key regulator of plasma HDL-C. LPL is mainly a triglyceride lipase regulating (V)LDL levels. The existing biological data indicate that inhibitors selective for EL over LPL should have anti-atherogenic activity, mainly through increasing plasma HDL-C levels. We report here the synthesis of alkyl, aryl, or acyl-substituted phenylboronic acids that inhibit EL. Many of the inhibitors evaluated proved to be nearly equally potent against both EL and LPL, but several exhibited moderate to good selectivity for EL. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.12.043
• 作为产物：
  描述：

  4-硝基苯酚三氟甲基磺酸酯 在 2-双环己基膦-2',6'-二甲氧基联苯 、 potassium phosphate monohydrate 、 palladium on activated charcoal 、 氢气 、 palladium diacetate 作用下， 以 乙醇 、 甲苯 为溶剂， 生成 4-氨基-4-氟联苯
  参考文献：
  名称：

  Design and synthesis of boronic acid inhibitors of endothelial lipase

  摘要：

  Endothelial lipase (EL) and lipoprotein lipase (LPL) are homologous lipases that act on plasma lipoproteins. EL is predominantly a phospholipase and appears to be a key regulator of plasma HDL-C. LPL is mainly a triglyceride lipase regulating (V)LDL levels. The existing biological data indicate that inhibitors selective for EL over LPL should have anti-atherogenic activity, mainly through increasing plasma HDL-C levels. We report here the synthesis of alkyl, aryl, or acyl-substituted phenylboronic acids that inhibit EL. Many of the inhibitors evaluated proved to be nearly equally potent against both EL and LPL, but several exhibited moderate to good selectivity for EL. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.12.043
• 作为试剂：
  描述：

  苯胺 、 4-fluorophenyldiazonium chloride 、 在 4-氟-联苯-2-胺 、 4-氨基-4-氟联苯 、 乙醚 、 苯胺 、 silica gel 、 ethyl acetate n-hexane 作用下， 以4′-Fluorobiphenyl-2-amine (0.85 mmol, 160 mg, 43%) and 4′-fluorobiphenyl-4-amine (0.16 mmol, 30 mg, 8%) were obtained的产率得到4-氟-联苯-2-胺
  参考文献：
  名称：

  Process for the Synthesis of Aminobiphenylene

  摘要：

  本发明涉及一种合成2-氨基联苯及其衍生物的方法，通过在碱性反应条件下将苯基重氮盐与苯胺化合物反应。

  公开号：

  US20130338369A1

文献信息

• The carbomethylation of arylacrylamides leading to 3-ethyl-3-substituted indolin-2-one by cascade radical addition/cyclization
  作者：Qiang Dai、Jintao Yu、Yan Jiang、Songjin Guo、Haitao Yang、Jiang Cheng

  DOI：10.1039/c4cc01053a

  日期：——

  An FeCl2-promoted carbomethylation of arylacrylamides by di-tert-butyl peroxide (DTBP) is achieved, leading to 3-ethyl-3-substituted indolin-2-one in high yield. The reaction tolerates a series of functional groups, such as cyano, nitro, ethyloxy carbonyl, bromo, chloro, and trifluoromethyl groups. The radical methylation and arylation of the alkenyl group are involved in this reaction.

  利用二叔丁基过氧化物（DTBP）实现的FeCl2促进的芳基丙烯酰胺的甲酸甲酯化反应，以高产率得到3-乙基-3-取代的吲哚啉-2-酮。该反应容忍一系列官能团，如氰基、硝基、乙氧羰基、溴、氯和三氟甲基等。反应涉及烯丙基的自由基甲基化和芳基化。
• Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3)
  作者：Qiuyao Huang、Yan Zhong、Bingbing Li、Shumin Ouyang、Lin Deng、Jianshan Mo、Shuo Shi、Nan Lv、Ruibo Wu、Peiqing Liu、Wenhao Hu、Xiaolei Zhang、Yuanxiang Wang

  DOI：10.1016/j.ejmech.2021.113525

  日期：2021.10

  of highly potent and selective STAT3 inhibitors, exemplified by compound 39 with the privileged structure of 2-phenylimidazo[1,2-a]pyridine, which selectively inhibits phosphorylation of STAT3 and suppresses subsequent signaling pathway. Moreover, 39 inhibits cell growth, migration and invasion of human triple negative breast cancer (TNBC) cells lines. Consistently, it achieves significant and dose-dependent

  由于其在癌症发生和发展中的重要作用，STAT3 已被证实为有吸引力的抗癌靶点。然而，发现具有类似药物特性的有效且选择性的 STAT3 小分子抑制剂仍然具有挑战性。在这项研究中，通过基于结构的药物发现方法，通过缩合STX-119和SH4-54的特权结构，设计了两个系列的取代 2-苯基喹啉和 2-芳基咪唑并[1,2-a]吡啶。我们的研究发现了许多高效和选择性的 STAT3 抑制剂，例如具有 2-苯基咪唑并[1,2-a]吡啶特权结构的化合物39，它选择性地抑制 STAT3 的磷酸化并抑制随后的信号通路. 而且，39抑制人三阴性乳腺癌 (TNBC) 细胞系的细胞生长、迁移和侵袭。一致地，它在小鼠的细胞系来源和患者来源的异种移植肿瘤模型中实现了显着且剂量依赖性的肿瘤生长抑制。这些结果清楚地表明39是一种高效且选择性的 STAT3 抑制剂。
• [EN] SMALL MOLECULE INDUCERS OF REACTIVE OXYGEN SPECIES AND INHIBITORS OF MITOCHONDRIAL ACTIVITY<br/>[FR] INDUCTEURS DE PETITES MOLÉCULES DE DÉRIVES RÉACTIFS DE L'OXYGÈNE ET INHIBITEURS DE L'ACTIVITÉ MITOCHONDRIALE
  申请人：UNIV MICHIGAN REGENTS

  公开号：WO2017155991A1

  公开（公告）日：2017-09-14

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a quinazolinedione structure which function as reactive oxygen species (ROS) inducers and inhibitors of mitochondrial activity within cancer cells (e.g., pancreatic cancer cells), and their use as therapeutics for the treatment of cancer (e.g., pancreatic cancer) and other diseases.

  这项发明属于药物化学领域。具体来说，该发明涉及一类具有喹唑啉二酮结构的小分子，其作为活性氧（ROS）诱导剂和对癌细胞（例如胰腺癌细胞）内线粒体活性的抑制剂，并将它们用作治疗癌症（例如胰腺癌）和其他疾病的药物。
• Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma
  作者：Yuting Kuang、Mario Sechi、Salvatore Nurra、Mats Ljungman、Nouri Neamati

  DOI：10.1021/acs.jmedchem.7b01463

  日期：2018.2.22

  modulators that we previously showed to induce potent growth inhibition in pancreatic ductal adenocarcinoma (PDAC) cell lines. Our lead optimization campaign yielded QD325 as the most potent redox modulator candidate inducing substantial reactive oxygen species (ROS) in PDAC cells. Nascent RNA sequencing following treatments with the QD compounds revealed induction of stress responses in nucleus, endoplasmic

  改变氧化还原稳态可以为胰腺癌的治疗提供独特的治疗机会。喹唑啉二酮（QDs）是新颖的氧化还原调节剂，我们先前已证明在胰腺导管腺癌（PDAC）细胞系中诱导有效的生长抑制作用。我们的领先优化活动使QD325成为最有力的氧化还原调节剂候选物，可在PDAC细胞中诱导大量的活性氧（ROS）。QD化合物处理后的新生RNA测序表明，胰腺癌细胞核，内质网和线粒体中应激反应的诱导。此外，QD化合物诱导Nrf2介导的氧化应激和未折叠的蛋白质反应，如代表性基因（如NQO1，HMOX1，DDIT3和HSPA5。在较高浓度下，量子点通过抑制mtDNA转录并下调mtDNA编码的OXPHOS酶来阻断线粒体功能。重要的是，QD325的治疗在体内具有良好的耐受性，并显着延迟了小鼠的肿瘤生长。我们的研究支持QD325作为PDAC治疗的新疗法的开发。
• Cubical Palladium Nanoparticles on C@Fe3O4 for Nitro reduction, Suzuki-Miyaura Coupling and Sequential Reactions
  作者：Basuvaraj Suresh Kumar、Arlin Jose Amali、Kasi Pitchumani

  DOI：10.1016/j.molcata.2016.08.003

  日期：2016.11

  Abstract Cubical Pd nanoparticles incorporated magnetically recyclable nanoreactor (Pd cNPs/C@Fe 3 O 4 ) are found to be efficient catalysts for the hydrogenation or aromatic nitrocompounds, Suzuki-Miyaura coupling and the sequential reaction of C C coupling followed by reduction of nitrobiphenyl substrates. A variety of aryl iodides, bromides and chlorides were coupled with phenylboronic acids to

  摘要 已发现掺入磁可回收纳米反应器 (Pd cNPs/C@Fe 3 O 4 ) 的立方 Pd 纳米粒子是氢化或芳族硝基化合物、Suzuki-Miyaura 偶联和 CC 偶联随后还原硝基联苯底物的顺序反应的有效催化剂。多种芳基碘化物、溴化物和氯化物与苯基硼酸偶联形成相应的联芳基产物，并对多种硝基芳族化合物进行加氢，收率高，TON。嵌入过量100}表面的钯立方纳米粒子（Pd cNPs）的催化活性优于嵌入混合表面刻面的Pd球形纳米粒子（Pd sNPs）。即使经过五次重复循环，催化效率也保持不变。观察到的催化活性增强归因于 Pd cNPs/C@Fe 3 O 4 催化剂表面存在的高密度低配位 Pd 100} 原子，这已通过 HR-TEM 研究得到证实。此外，该催化剂是真正的多相催化剂，高度稳定，不需要任何有毒配体，在硝基还原和 Suzuki-Miyaura 偶联反应中具有广泛的底物范围，以及以